Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, MR Spiegel, PW Johnson, ER Lesser… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, KA Bruno, AM Klompas, ER Lesser… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience
…, CC Wiggins, KA Bruno, AM Klompas, ER Lesser… - medrxiv, 2020 - medrxiv.org
Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …
diseases that involve the respiratory system. In this context, human convalescent plasma has …
Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression
…, ME Murray, AM Liesinger, MG Heckman, ER Lesser… - Brain, 2019 - academic.oup.com
While the accumulation and aggregation of amyloid-β and tau are central events in the
pathogenesis of Alzheimer’s disease, there is increasing evidence that cerebrovascular …
pathogenesis of Alzheimer’s disease, there is increasing evidence that cerebrovascular …
[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
…, KF Larson, JG Ripoll, KJ Andersen, ER Lesser… - Nature …, 2021 - nature.com
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
[HTML][HTML] Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer's disease
…, NO Azu, AM Liesinger, ER Lesser… - Nature …, 2021 - nature.com
Selective vulnerability of different brain regions is seen in many neurodegenerative
disorders. The hippocampus and cortex are selectively vulnerable in Alzheimer’s disease (AD), …
disorders. The hippocampus and cortex are selectively vulnerable in Alzheimer’s disease (AD), …
Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease
FSH Al-Shaikh, R Duara, JE Crook, ER Lesser… - JAMA …, 2020 - jamanetwork.com
Importance Corticolimbic patterns of neurofibrillary tangle (NFT) accumulation define
neuropathologic subtypes of Alzheimer disease (AD), which underlie the clinical heterogeneity …
neuropathologic subtypes of Alzheimer disease (AD), which underlie the clinical heterogeneity …
[HTML][HTML] Structural connectivity–based segmentation of the thalamus and prediction of tremor improvement following thalamic deep brain stimulation of the ventral …
Objectives Traditional targeting methods for thalamic deep brain stimulation (DBS) performed
to address tremor have predominantly relied on indirect atlas-based methods that focus on …
to address tremor have predominantly relied on indirect atlas-based methods that focus on …
[HTML][HTML] Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort
…, AM Liesinger, KF Bieniek, KM Hinkle, ER Lesser… - Alzheimer's & …, 2019 - Elsevier
Introduction Our primary goal was to examine demographic and clinicopathologic differences
across an ethnoracially diverse autopsy-confirmed cohort of Alzheimer's disease cases. …
across an ethnoracially diverse autopsy-confirmed cohort of Alzheimer's disease cases. …